Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pain × Patient Reported Outcome Measures × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 6 Breast Neoplasms 6 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Leukemia 3 Carcinoma, Non-Small-Cell Lung 3 Radiation Injuries 2 Preleukemia 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Precancerous Conditions 2 Neoplasms by Histologic Type 2 Myelodysplastic Syndromes 2 Multiple Myeloma 2 Multiple Chronic Conditions 2 Lymphoproliferative Disorders 2 Lymphoma 2 Lymphatic Diseases 2 Leukemia, Myeloid, Acute 2 Leukemia, Myeloid 2 Leukemia, Lymphoid 2 Leukemia, Biphenotypic, Acute 2 Leukemia, B-Cell 2 Immunoproliferative Disorders 2 Immune System Diseases 2 Hematologic Diseases 2 Esophageal Neoplasms 2 Cognitive Dysfunction 2 Brain Neoplasms 2 Bone Marrow Diseases 2 Thoracic Neoplasms 1

Interventions

Fentanyl 24 Analgesia 21 Morphine 17 Acupuncture Therapy 17 Surveys and Questionnaires 15 Zoledronic Acid 13 Therapeutics 13 Oxycodone 13 Acetaminophen 13 Psychiatric Rehabilitation 12 Ketamine 12 Radiotherapy 11 Lidocaine 11 Hydromorphone 11 Methadone 10 Ibandronic Acid 10 nabiximols 9 Ropivacaine 9 Bupivacaine 9 Analgesics, Opioid 7 Early Intervention, Educational 6 Water 5 Tapentadol 5 Pregabalin 5 Music Therapy 5 Methods 5 Docetaxel 5 Cryotherapy 5 Cryosurgery 5 Control Groups 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05684939 2023-06-13

CAPS

University Hospital, Clermont-Ferrand

Neoplasms, Pain, Substance-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡